financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Dorian LPG's Fiscal Q3 Adjusted Earnings, Revenue Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dorian LPG's Fiscal Q3 Adjusted Earnings, Revenue Fall
Jan 31, 2025 4:04 AM

06:34 AM EST, 01/31/2025 (MT Newswires) -- Dorian LPG ( LPG ) reported fiscal Q3 adjusted earnings Friday of $0.43 per diluted share, down from $2.62 a year earlier.

Analysts polled by FactSet expected $0.52.

Revenue for the quarter ended Dec. 31 was $80.7 million compared with $163.1 million a year earlier.

Analysts surveyed by FactSet expected $85.7 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Johnson & Johnson To Obtain Rights To A Clinical-Stage Bispecific Antibody To Address Distinct Patient Needs In Atopic Dermatitis
BRIEF-Johnson & Johnson To Obtain Rights To A Clinical-Stage Bispecific Antibody To Address Distinct Patient Needs In Atopic Dermatitis
May 28, 2024
May 28 (Reuters) - Johnson & Johnson: * JOHNSON & JOHNSON TO OBTAIN RIGHTS TO A CLINICAL-STAGE BISPECIFIC ANTIBODY TO ADDRESS DISTINCT PATIENT NEEDS IN ATOPIC DERMATITIS * J&J - PROPOSED DEAL FOR ALL-CASH TRANSACTION OF APPROXIMATELY $1.25 BILLION * J&J - PROPOSED DEAL FOR ALL-CASH TRANSACTION OF APPROXIMATELY $1.25 BILLION * J&J: ENTERS AGREEMENT WITH NUMAB THERAPEUTICS TO ACQUIRE...
 BRIEF-Numab Therapeutics Announces Johnson & Johnson To Acquire Its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights To Nm26, A Bi-Specific Antibody For The Treatment Of Atopic Derm
BRIEF-Numab Therapeutics Announces Johnson & Johnson To Acquire Its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights To Nm26, A Bi-Specific Antibody For The Treatment Of Atopic Derm
May 28, 2024
May 28 (Reuters) - Johnson & Johnson ( JNJ ): * NUMAB THERAPEUTICS ANNOUNCES JOHNSON & JOHNSON TO ACQUIRE ITS WHOLLY-OWNED SUBSIDIARY YELLOW JERSEY THERAPEUTICS INCLUDING RIGHTS TO NM26, A BI-SPECIFIC ANTIBODY FOR THE TREATMENT OF ATOPIC DERMATITIS Source text for Eikon: Further company coverage: ...
 Novelis Files to Offer 45 Million Common Shares in IPO
Novelis Files to Offer 45 Million Common Shares in IPO
May 28, 2024
07:38 AM EDT, 05/28/2024 (MT Newswires) -- Novelis filed on May 28 to offer 45 million common shares in its initial public offering with an estimated price per share of between $18 to $21. ...
 BRIEF-Transdigm Announces Acquisition Of Raptor Scientific
BRIEF-Transdigm Announces Acquisition Of Raptor Scientific
May 28, 2024
May 28 (Reuters) - TransDigm Group Inc ( TDG ): * TRANSDIGM ANNOUNCES ACQUISITION OF RAPTOR SCIENTIFIC Source text for Eikon: Further company coverage: ...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved